CN104706792A - 复方土霉素滴眼液 - Google Patents
复方土霉素滴眼液 Download PDFInfo
- Publication number
- CN104706792A CN104706792A CN201510131348.9A CN201510131348A CN104706792A CN 104706792 A CN104706792 A CN 104706792A CN 201510131348 A CN201510131348 A CN 201510131348A CN 104706792 A CN104706792 A CN 104706792A
- Authority
- CN
- China
- Prior art keywords
- oxytetracycline
- eye drop
- parts
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004100 Oxytetracycline Substances 0.000 title claims abstract description 41
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 title claims abstract description 41
- 229960000625 oxytetracycline Drugs 0.000 title claims abstract description 41
- 235000019366 oxytetracycline Nutrition 0.000 title claims abstract description 41
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 239000003889 eye drop Substances 0.000 title claims abstract description 40
- 229940012356 eye drops Drugs 0.000 title abstract description 8
- 150000001875 compounds Chemical class 0.000 title abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 9
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 238000005374 membrane filtration Methods 0.000 claims description 4
- 239000003610 charcoal Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 241000205585 Aquilegia canadensis Species 0.000 abstract description 2
- 235000013717 Houttuynia Nutrition 0.000 abstract description 2
- 240000000691 Houttuynia cordata Species 0.000 abstract description 2
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 23
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 230000028327 secretion Effects 0.000 description 9
- 241000193755 Bacillus cereus Species 0.000 description 7
- 241000192041 Micrococcus Species 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 210000004087 cornea Anatomy 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 4
- 241000588747 Klebsiella pneumoniae Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 4
- 229960001225 rifampicin Drugs 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 206010011033 Corneal oedema Diseases 0.000 description 3
- 206010015943 Eye inflammation Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 201000004778 corneal edema Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001408 fungistatic effect Effects 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 206010023683 lagophthalmos Diseases 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 206010060976 Bacillus infection Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 208000001860 Eye Infections Diseases 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 241000498849 Chlamydiales Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 241000187419 Streptomyces rimosus Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 206010015915 eye discharge Diseases 0.000 description 1
- 208000011323 eye infectious disease Diseases 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 变化情况 |
实施例1 | 土霉素和中药组合物的重量比例为1:550(土霉素100mg) |
实施例2 | 土霉素和中药组合物的重量比例为2:550(土霉素200mg) |
对比实施例1 | 仅包括土霉素200mg,无中药组合物 |
对比实施例2 | 仅包括中药组合物(用量翻倍),无土霉素 |
对比实施例3 | 土霉素和中药组合物的重量比例为5:550(土霉素500mg) |
对比实施例4 | 中药组合物中各成分用量改变 |
对比实施例5 | 中药组合物中成分改变 |
对比实施例6 | 土霉素变为利福平 |
对比实施例7 | 市售利福平滴眼液 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510131348.9A CN104706792B (zh) | 2015-03-25 | 2015-03-25 | 复方土霉素滴眼液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510131348.9A CN104706792B (zh) | 2015-03-25 | 2015-03-25 | 复方土霉素滴眼液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104706792A true CN104706792A (zh) | 2015-06-17 |
CN104706792B CN104706792B (zh) | 2017-11-24 |
Family
ID=53406836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510131348.9A Active CN104706792B (zh) | 2015-03-25 | 2015-03-25 | 复方土霉素滴眼液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104706792B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308107A (zh) * | 2017-07-06 | 2017-11-03 | 山东中牧兽药有限公司 | 一种长效土霉素注射液及其制备方法 |
CN108420882A (zh) * | 2018-05-16 | 2018-08-21 | 中国人民解放军陆军军医大学第附属医院 | 肝素钠滴眼液 |
CN108743604A (zh) * | 2018-05-16 | 2018-11-06 | 中国人民解放军陆军军医大学第附属医院 | 高糖滴眼液 |
CN113876863A (zh) * | 2021-10-28 | 2022-01-04 | 庞笠民 | 一种纯植物护眼液中的功效组合物、及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1575814A (zh) * | 2003-07-11 | 2005-02-09 | 成都三明药物研究所 | 一种眼用药物组合物及其制备方法和用途 |
-
2015
- 2015-03-25 CN CN201510131348.9A patent/CN104706792B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1575814A (zh) * | 2003-07-11 | 2005-02-09 | 成都三明药物研究所 | 一种眼用药物组合物及其制备方法和用途 |
Non-Patent Citations (3)
Title |
---|
中国医学会上海分会: "《上海市医院制剂手册 第二版》", 30 September 1983, 上海科学技术出版社 * |
姚九莲: "《中药外用指南》", 31 May 2000, 金盾出版社 * |
陈小刚: "《常用中草药临床新用》", 31 March 2005, 广东科技出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308107A (zh) * | 2017-07-06 | 2017-11-03 | 山东中牧兽药有限公司 | 一种长效土霉素注射液及其制备方法 |
CN108420882A (zh) * | 2018-05-16 | 2018-08-21 | 中国人民解放军陆军军医大学第附属医院 | 肝素钠滴眼液 |
CN108743604A (zh) * | 2018-05-16 | 2018-11-06 | 中国人民解放军陆军军医大学第附属医院 | 高糖滴眼液 |
CN113876863A (zh) * | 2021-10-28 | 2022-01-04 | 庞笠民 | 一种纯植物护眼液中的功效组合物、及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104706792B (zh) | 2017-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104706792A (zh) | 复方土霉素滴眼液 | |
CN104542740A (zh) | 一种用于检验科器械杀菌消毒的中药消毒液及制备方法 | |
CN104605013B (zh) | 一种唐松草属植物提取物的制备方法及其制备的唐松草属植物提取物和用途 | |
CN101766628A (zh) | 一种眼科外用抗细菌感染药物 | |
CN104940239B (zh) | 一种蟑螂提取物及其制备方法和用途 | |
CN111407817A (zh) | 一种预防呼吸道感染病原微生物的中药组合物及其制备方法 | |
CN108853358B (zh) | 一种抗菌中药组合物及其制备方法和用途 | |
CN110300616A (zh) | 用于治疗泌尿生殖器官的病症的组合物 | |
CN113318149B (zh) | 一种素馨花提取物及其制备方法和应用 | |
CN110638985A (zh) | 治疗妇科炎症的中药组合物凝胶栓剂及其制备方法 | |
CN106334149A (zh) | 一种莪术油及其药物制剂 | |
CN104758635A (zh) | 复方土霉素眼膏 | |
CN106619829A (zh) | 一种抗金黄色葡萄球菌的药物及制备方法和用途 | |
Tefera et al. | In vitro anti-Neisseria gonorrhoeae activity of Albizia gummifera and Croton macrostachyus | |
CN105963334A (zh) | 牛蒡子提取物及其制备方法与在抑菌中的应用 | |
CN105943718B (zh) | 一种沉香复方中药组合物及其制备方法、应用 | |
CN112471180A (zh) | 一种中药消毒液及其制作方法 | |
CN107349376B (zh) | 一种抗鸡球虫益生药物及其制备方法和应用 | |
CN104083443B (zh) | 复方妥布霉素滴眼液 | |
CN107050086A (zh) | 一种眼科清洗剂及其制备方法 | |
CN104069118B (zh) | 滴眼液及其制备方法 | |
CN113559270B (zh) | 抗菌组合物、应用及包含其的产品 | |
CN114129635B (zh) | 含辣椒提取物的抗菌组合物及其应用 | |
CN102895282B (zh) | 一种板蓝根提取液与纳米银抑菌组合物 | |
CN114366730B (zh) | 没食子酸及包含其的药物组合物用于治疗细菌性前列腺炎的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Hou Aiping Inventor before: Liu Ying |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171030 Address after: Yucai Road 276002 Shandong city of Linyi province Lanshan District No. 109 Applicant after: Hou Aiping Address before: 610000 Sichuan city of Chengdu province high tech Zone Kyrgyzstan Road No. 666 Building 2 floor 13 No. 2 Applicant before: Chengdu Hui Zhi distant view Science and Technology Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201209 Address after: Room 1004-14, building 8, 3333 Guangyi Road, Daqiao Town, Nanhu District, Jiaxing City, Zhejiang Province Patentee after: Jiaxing Jingchen Environmental Protection Technology Co., Ltd Address before: No.109 Yucai Road, Lanshan District, Linyi City, Shandong Province Patentee before: Hou Aiping |
|
TR01 | Transfer of patent right |
Effective date of registration: 20211111 Address after: 037034 No. 3, Tongyun Road, Datong City, Shanxi Province Patentee after: Datong Tongxing antibiotic Co., Ltd Address before: 314001 room 1004, building 8, No. 3333, Guangyi Road, Daqiao Town, Nanhu District, Jiaxing City, Zhejiang Province Patentee before: Jiaxing Jingchen Environmental Protection Technology Co., Ltd |
|
TR01 | Transfer of patent right |